Robeco Institutional Asset Management
CORT icon

Robeco Institutional Asset Management’s Corcept Therapeutics CORT Stock Holding History

Robeco Institutional Asset Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,107
Closed -$355K – 878
2025
Q1 		$355K Buy
+3,107
New +$189K ﹤0.01% 855
2024
Q4 		– Sell
-6,436
Closed -$298K – 907
2024
Q3 		$298K Sell
6,436
-12,805
-67% -$455K ﹤0.01% 868
2024
Q2 		$625K Sell
19,241
-2,467
-11% -$67.6K ﹤0.01% 820
2024
Q1 		$547K Sell
21,708
-10,299
-32% -$243K ﹤0.01% 825
2023
Q4 		$1.04M Buy
32,007
+11,545
+56% +$317K ﹤0.01% 778
2023
Q3 		$557K Hold
20,462
– – ﹤0.01% 833
2023
Q2 		$455K Sell
20,462
-10,797
-35% -$249K ﹤0.01% 867
2023
Q1 		$677K Hold
31,259
– – ﹤0.01% 819
2022
Q4 		$635K Buy
31,259
+6,809
+28% +$171K ﹤0.01% 815
2022
Q3 		$626K Sell
24,450
-4,512
-16% -$121K ﹤0.01% 750
2022
Q2 		$689K Buy
28,962
+291
+1% +$6.34K ﹤0.01% 731
2022
Q1 		$645K Hold
28,671
– – ﹤0.01% 748
2021
Q4 		$567K Hold
28,671
– – ﹤0.01% 758
2021
Q3 		$564K Hold
28,671
– – ﹤0.01% 763
2021
Q2 		$631K Sell
28,671
-10,511
-27% -$234K ﹤0.01% 778
2021
Q1 		$932K Sell
39,182
-10,596
-21% -$283K ﹤0.01% 738
2020
Q4 		$1.3M Sell
49,778
-6,513
-12% -$137K ﹤0.01% 708
2020
Q3 		$981K Buy
56,291
+12,538
+29% +$200K ﹤0.01% 715
2020
Q2 		$736K Hold
43,753
– – ﹤0.01% 771
2020
Q1 		$520K Buy
43,753
+21,782
+99% +$270K ﹤0.01% 811
2019
Q4 		$266K Hold
21,971
– – ﹤0.01% 882
2019
Q3 		$310K Buy
+21,971
New +$270K ﹤0.01% 866
2018
Q2 		– Sell
-17,624
Closed -$290K – 964
2018
Q1 		$290K Hold
17,624
– – ﹤0.01% 848
2017
Q4 		$318K Hold
17,624
– – ﹤0.01% 804
2017
Q3 		$340K Hold
17,624
– – ﹤0.01% 749
2017
Q2 		$208K Buy
+17,624
New +$192K ﹤0.01% 804

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Robeco Institutional Asset Management's CORT Position: Q2 2025 in Review

Robeco Institutional Asset Management sold out of Corcept Therapeutics (CORT) in Q2 2025, closing a stake of 3,107 shares — an estimated $355K sold.

Robeco Institutional Asset Management first reported a position in CORT in Q2 2017 and held it in 26 quarters. The position peaked at $1.3M in Q4 2020. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2025.

  • Robeco Institutional Asset Management reported no remaining Corcept Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 3,107 Corcept Therapeutics shares in Q2 2025, an estimated $355K.
  • Robeco Institutional Asset Management first reported a position in Corcept Therapeutics in Q2 2017 and held it in 26 quarters.
  • Robeco Institutional Asset Management's Corcept Therapeutics position peaked at $1.3M in Q4 2020.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2025.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2025, filed 18 Jul 2025.